[United States Statutes at Large, Volume 127, 113th Congress, 1st Session]
[From the U.S. Government Publishing Office, www.gpo.gov]


Public Law 113-55
113th Congress

An Act


 
To reduce preterm labor and delivery and the risk of pregnancy-related
deaths and complications due to pregnancy, and to reduce infant
mortality caused by prematurity, and for other purposes. <>

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. TABLE OF CONTENTS.

The table of contents for this Act is as follows:

Sec. 1. Table of contents.

TITLE I--PREEMIE ACT REAUTHORIZATION

Sec. 101. Short title.
Sec. 102. Research and activities at the Centers for Disease Control and
Prevention.
Sec. 103. Activities at the Health Resources and Services
Administration.
Sec. 104. Other activities.

TITLE II--NATIONAL PEDIATRIC RESEARCH NETWORK

Sec. 201. Short title.
Sec. 202. National Pediatric Research Network.

TITLE III--CHIMP ACT AMENDMENTS

Sec. 301. Short title.
Sec. 302. Care for NIH chimpanzees.

TITLE <>  I--
PREEMIE ACT REAUTHORIZATION
SEC. 101. SHORT TITLE.

This title may be cited as the ``Prematurity Research Expansion and
Education for Mothers who deliver Infants Early Reauthorization Act'' or
the ``PREEMIE Reauthorization Act''.
SEC. 102. RESEARCH AND ACTIVITIES AT THE CENTERS FOR DISEASE
CONTROL AND PREVENTION.

(a) Epidemiological Studies.--Section 3 of the Prematurity Research
Expansion and Education for Mothers who deliver Infants Early Act (42
U.S.C. 247b-4f) is amended by striking subsection (b) and inserting the
following:
``(b) Studies and Activities on Preterm Birth.--
``(1) In general.--The Secretary of Health and Human
Services, acting through the Director of the Centers for Disease
Control and Prevention, may, subject to the availability of
appropriations--

[[Page 642]]

``(A) conduct epidemiological studies on the
clinical, biological, social, environmental, genetic,
and behavioral factors relating to prematurity, as
appropriate;
``(B) conduct activities to improve national data to
facilitate tracking the burden of preterm birth; and
``(C) continue efforts to prevent preterm birth,
including late preterm birth, through the identification
of opportunities for prevention and the assessment of
the impact of such efforts.
``(2) Report.--Not later than 2 years after the date of
enactment of the PREEMIE Reauthorization Act, and every 2 years
thereafter, the Secretary of Health and Human Services, acting
through the Director of the Centers for Disease Control and
Prevention, shall submit to the appropriate committees of
Congress reports concerning the progress and any results of
studies conducted under paragraph (1).''.

(b) Reauthorization.--Section 3(e) of the Prematurity Research
Expansion and Education for Mothers who deliver Infants Early Act (42
U.S.C. 247b-4f(e)) is amended by striking ``$5,000,000'' and all that
follows through ``2011.'' and inserting ``$1,880,000 for each of fiscal
years 2014 through 2018.''.
SEC. 103. ACTIVITIES AT THE HEALTH RESOURCES AND SERVICES
ADMINISTRATION.

(a) Telemedicine and High-Risk Pregnancies.--Section 330I(i)(1)(B)
of the Public Health Service Act (42 U.S.C. 254c-14(i)(1)(B)) is amended
by striking ``or case management services'' and inserting ``case
management services, or prenatal care for high-risk pregnancies'';
(b) Public and Health Care Provider Education.--Section 399Q of the
Public Health Service Act (42 U.S.C. 280g-5) is amended--
(1) in subsection (b)--
(A) in paragraph (1), by striking subparagraphs (A)
through (F) and inserting the following:
``(A) the core risk factors for preterm labor and
delivery;
``(B) medically indicated deliveries before full
term;
``(C) the importance of preconception and prenatal
care, including--
``(i) smoking cessation;
``(ii) weight maintenance and good nutrition,
including folic acid;
``(iii) the screening for and the treatment of
infections; and
``(iv) stress management;
``(D) treatments and outcomes for premature infants,
including late preterm infants;
``(E) the informational needs of families during the
stay of an infant in a neonatal intensive care unit; and
``(F) utilization of evidence-based strategies to
prevent birth injuries;''; and
(B) by striking paragraph (2) and inserting the
following:
``(2) programs to increase the availability, awareness, and
use of pregnancy and post-term information services that provide
evidence-based, clinical information through counselors,

[[Page 643]]

community outreach efforts, electronic or telephonic
communication, or other appropriate means regarding causes
associated with prematurity, birth defects, or health risks to a
post-term infant;''; and
(2) in subsection (c), by striking ``$5,000,000'' and all
that follows through ``2011.'' and inserting ``$1,900,000 for
each of fiscal years 2014 through 2018.''.
SEC. 104. OTHER ACTIVITIES.

(a) Interagency Coordinating Council on Prematurity and Low
Birthweight.--The Prematurity Research Expansion and Education for
Mothers who deliver Infants Early Act is amended by striking section 5
(42 U.S.C. 247b-4g).
(b) <>  Advisory Committee on Infant
Mortality.--
(1) Establishment.--The Secretary of Health and Human
Services (referred to in this section as the ``Secretary'') may
establish an advisory committee known as the ``Advisory
Committee on Infant Mortality'' (referred to in this section as
the ``Advisory Committee'').
(2) Duties.--The Advisory Committee shall provide advice and
recommendations to the Secretary concerning the following
activities:
(A) Programs of the Department of Health and Human
Services that are directed at reducing infant mortality
and improving the health status of pregnant women and
infants.
(B) Strategies to coordinate the various Federal
programs and activities with State, local, and private
programs and efforts that address factors that affect
infant mortality.
(C) Implementation of the Healthy Start program
under section 330H of the Public Health Service Act (42
U.S.C. 254c-8) and Healthy People 2020 infant mortality
objectives.
(D) Strategies to reduce preterm birth rates through
research, programs, and education.
(3) <>  Plan for hhs preterm birth
activities.--Not later than 1 year after the date of enactment
of this section, the Advisory Committee (or an advisory
committee in existence as of the date of enactment of this Act
and designated by the Secretary) shall develop a plan for
conducting and supporting research, education, and programs on
preterm birth through the Department of Health and Human
Services and shall periodically review and revise the plan, as
appropriate. The plan shall--
(A) examine research and educational activities that
receive Federal funding in order to enable the plan to
provide informed recommendations to reduce preterm birth
and address racial and ethnic disparities in preterm
birth rates;
(B) identify research gaps and opportunities to
implement evidence-based strategies to reduce preterm
birth rates among the programs and activities of the
Department of Health and Human Services regarding
preterm birth, including opportunities to minimize
duplication; and
(C) reflect input from a broad range of scientists,
patients, and advocacy groups, as appropriate.

[[Page 644]]

(4) Membership.--The Secretary shall ensure that the
membership of the Advisory Committee includes the following:
(A) Representatives provided for in the original
charter of the Advisory Committee.
(B) A representative of the National Center for
Health Statistics.

(c) Patient Safety Studies and Report.--
(1) In general.--The Secretary shall designate an
appropriate agency within the Department of Health and Human
Services to coordinate existing studies on hospital readmissions
of preterm infants.
(2) Report to secretary and congress.--Not later than 1 year
after the date of the enactment of this Act, the agency
designated under paragraph (1) shall submit to the Secretary and
to Congress a report containing the findings and recommendations
resulting from the studies coordinated under such paragraph,
including recommendations for hospital discharge and followup
procedures designed to reduce rates of preventable hospital
readmissions for preterm infants.

TITLE <>  II--NATIONAL PEDIATRIC RESEARCH NETWORK
SEC. 201. SHORT TITLE.

This title may be cited as the ``National Pediatric Research Network
Act of 2013''.
SEC. 202. NATIONAL PEDIATRIC RESEARCH NETWORK.

Section 409D of the Public Health Service Act (42 U.S.C. 284h;
relating to the Pediatric Research Initiative) is amended--
(1) by redesignating subsection (d) as subsection (f); and
(2) by inserting after subsection (c) the following:

``(d) National Pediatric Research Network.--
``(1) Network.--In carrying out the Initiative, the Director
of NIH, in consultation with the Director of the Eunice Kennedy
Shriver National Institute of Child Health and Human Development
and in collaboration with other appropriate national research
institutes and national centers that carry out activities
involving pediatric research, may provide for the establishment
of a National Pediatric Research Network in order to more
effectively support pediatric research and optimize the use of
Federal resources. Such National Pediatric Research Network may
be comprised of, as appropriate--
``(A) the pediatric research consortia receiving
awards under paragraph (2); or
``(B) other consortia, centers, or networks focused
on pediatric research that are recognized by the
Director of NIH and established pursuant to the
authorities vested in the National Institutes of Health
by other sections of this Act.
``(2) Pediatric research consortia.--
``(A) In general.--The Director of NIH may award
funding, including through grants, contracts, or other
mechanisms, to public or private nonprofit entities for
providing support for pediatric research consortia,
including with respect to--

[[Page 645]]

``(i) basic, clinical, behavioral, or
translational research to meet unmet needs for
pediatric research; and
``(ii) training researchers in pediatric
research techniques in order to address unmet
pediatric research needs.
``(B) Research.--The Director of NIH shall, as
appropriate, ensure that--
``(i) each consortium receiving an award under
subparagraph (A) conducts or supports at least one
category of research described in subparagraph
(A)(i) and collectively such consortia conduct or
support such categories of research; and
``(ii) one or more such consortia provide
training described in subparagraph (A)(ii).
``(C) Organization of consortium.--Each consortium
receiving an award under subparagraph (A) shall--
``(i) be formed from a collaboration of
cooperating institutions;
``(ii) be coordinated by a lead institution or
institutions;
``(iii) agree to disseminate scientific
findings, including from clinical trials, rapidly
and efficiently, as appropriate, to--
``(I) other consortia;
``(II) the National Institutes of
Health;
``(III) the Food and Drug
Administration;
``(IV) and other relevant agencies;
and
``(iv) meet such requirements as may be
prescribed by the Director of NIH.
``(D) Supplement, not supplant.--Any support
received by a consortium under subparagraph (A) shall be
used to supplement, and not supplant, other public or
private support for activities authorized to be
supported under this paragraph.
``(E) Duration of support.--Support of a consortium
under subparagraph (A) may be for a period of not to
exceed 5 years. Such period may be extended at the
discretion of the Director of NIH.
``(3) Coordination of consortia activities.--The Director of
NIH shall, as appropriate--
``(A) provide for the coordination of activities
(including the exchange of information and regular
communication) among the consortia established pursuant
to paragraph (2); and
``(B) <>  require the periodic
preparation and submission to the Director of reports on
the activities of each such consortium.
``(4) Assistance with registries.--Each consortium receiving
an award under paragraph (2)(A) may provide assistance, as
appropriate, to the Centers for Disease Control and Prevention
for activities related to patient registries and other
surveillance systems upon request by the Director of the Centers
for Disease Control and Prevention.

``(e) Research on Pediatric Rare Diseases or Conditions.--In making
awards under subsection (d)(2) for pediatric research consortia, the
Director of NIH shall ensure that an appropriate

[[Page 646]]

number of such awards are awarded to such consortia that agree to--
``(1) consider pediatric rare diseases or conditions, or
those related to birth defects; and
``(2) conduct or coordinate one or more multisite clinical
trials of therapies for, or approaches to, the prevention,
diagnosis, or treatment of one or more pediatric rare diseases
or conditions.''.

TITLE <>  III--CHIMP ACT AMENDMENTS
SEC. <>  301. SHORT TITLE.

This title may be cited as the ``CHIMP Act Amendments of 2013''.
SEC. 302. CARE FOR NIH CHIMPANZEES.

(a) In General.--Section 404K(g) of the Public Health Service Act
(42 U.S.C. 283m(g)) is amended--
(1) by amending paragraph (1) to read as follows:
``(1) <>  In general.--
Of the amount appropriated for the National Institutes of
Health, there are authorized to be appropriated to carry out
this section and for the care, maintenance, and transportation
of all chimpanzees otherwise under the ownership or control of
the National Institutes of Health, and to enable the National
Institutes of Health to operate more efficiently and
economically by decreasing the overall Federal cost of providing
for the care, maintenance, and transportation of chimpanzees--
``(A) for fiscal year 2014, $12,400,000;
``(B) for fiscal year 2015, $11,650,000;
``(C) for fiscal year 2016, $10,900,000;
``(D) for fiscal year 2017, $10,150,000; and
``(E) for fiscal year 2018, $9,400,000.'';
(2) by striking paragraph (2);
(3) by redesignating paragraph (3) as paragraph (2); and
(4) in paragraph (2), as so redesignated--
(A) by striking ``With respect to amounts reserved
under paragraph (1)'' and inserting ``With respect to
amounts authorized to be appropriated by paragraph
(1)''; and
(B) by striking ``board of directors'' and inserting
``Secretary in consultation with the board of
directors''.

(b) <>  GAO Study.--Not later than 2 years
after the date of enactment of this Act, the Comptroller General of the
United States shall conduct an independent evaluation, and submit to the
appropriate committees of Congress a report, regarding chimpanzees under
the ownership or control the National Institutes of Health. Such report
shall review and assess--
(1) the research status of such chimpanzees;
(2) the cost for the care, maintenance, and transportation
of such chimpanzees, including the cost broken down by--
(A) research or retirement status;
(B) services included in the care, maintenance, and
transportation; and
(C) location;

[[Page 647]]

(3) the extent to which matching requirements have been met
pursuant to section 404K(e)(4) of the Public Health Service Act
(42 U.S.C. 283m(e)(4)); and
(4) any options for cost savings for the support and
maintenance of such chimpanzees.

(c) Biennial Report.--Section 404K(g) of the Public Health Service
Act (42 U.S.C. 283m(g)) is amended by adding at the end the following:
``(3) Biennial report.--Not later than 180 days after the
date enactment of this Act, the Director of the National
Institutes of Health shall submit to the Committee on Health,
Education, Labor, and Pensions and the Committee on
Appropriations of the Senate and the Committee on Energy and
Commerce and the Committee on Appropriations in the House of
Representatives a report, to be updated biennially, regarding--
``(A) the care, maintenance, and transportation of
the chimpanzees under the ownership or control of the
National Institutes of Health;
``(B) costs related to such care, maintenance, and
transportation, and any other related costs; and
``(C) the research status of such chimpanzees.''.

Approved November 27, 2013.

LEGISLATIVE HISTORY--S. 252:
---------------------------------------------------------------------------

CONGRESSIONAL RECORD, Vol. 159 (2013):
Sept. 24, considered and passed Senate.
Nov. 12, considered and passed House, amended.
Nov. 14, Senate concurred in House amendments.